Tag: Agrisoma Biosciences

Agrisoma Biosciences scores C$12 million investment round

Agrisoma Biosciences scores C$12 million investment round

March 15, 2018 |

In Canada, Agrisoma Biosciences Inc. announced it has completed a C$12 million investment round. In addition to new investor Desjardins Capital, the lead investor Cycle Capital Management and existing investors BDC Capital and Lune Rouge also participated in the round. “The biofuel developed by Agrisoma allows for a major change in the greenhouse gas emissions […]

Read More

Agrisoma expands aviation biofuel partnership with University of Florida

Agrisoma expands aviation biofuel partnership with University of Florida

October 3, 2017 |

In Canada, Agrisoma Biosciences Inc., is expanding its partnership with the University of Florida (UF) to advance the supply of bio jet fuel in the United States. The Quebec-based company and its subsidiary, Agrisoma USA, is working with a network of 40 academic researchers from seven Universities associated with UF’s Institute of Food and Agricultural […]

Read More

Agrisoma Biosciences closes $8 million in Series A funding

Agrisoma Biosciences closes $8 million in Series A funding

September 29, 2014 |

In Canada, Agrisoma Biosciences announced the first closing of its Series A financing round, expected to total $8 million through 2014. The funding round was led by Cycle Capital Management and included participation of BDC Venture Capital, one of Agrisoma’s current equity investors. The funding is in support of Agrisoma’s further commercialization of Resonance® Carinata, […]

Read More

Agrisoma Biosciences receives BIOTECanada’s Gold Leaf Award

Agrisoma Biosciences receives BIOTECanada’s Gold Leaf Award

June 18, 2014 |

In Canada, Agrisoma Biosciences has been awarded the Gold Leaf Award as “Company of the Year”, by BIOTECanada for biotechnology excellence in Canada. The Gold Leaf Awards are nominated and judged by biotechnology industry leaders, and the awards honour companies that have made significant contributions to the growth of Canada’s biotech sector.  

Read More